MedPath

Rapiscan 400mcg solucion inyectable

Rapiscan 400mcg solucion inyectable

Commercialized
Register Number

110643001

Prescription Type

Uso Hospitalario

Authorization Date

Jun 28, 2013

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number110643001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

REGADENOSONActive
Quantity: 400 µg
Name: REGADENOSON

ATC CLASSIFICATION (3)

C01E
C01EB
C01EB21

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.